Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Transmedics Group Inc (TMDX)

Transmedics Group Inc (TMDX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 787,837
  • Shares Outstanding, K 27,624
  • Annual Sales, $ 25,640 K
  • Annual Income, $ -28,750 K
  • 60-Month Beta 2.00
  • Price/Sales 31.46
  • Price/Cash Flow N/A
  • Price/Book 8.26
Trade TMDX with:

Options Overview

Details
  • Implied Volatility 90.89%
  • Historical Volatility 68.79%
  • IV Percentile 37%
  • IV Rank 20.16%
  • IV High 209.32% on 10/21/20
  • IV Low 60.99% on 10/07/20
  • Put/Call Vol Ratio 0.13
  • Today's Volume 134
  • Volume Avg (30-Day) 460
  • Put/Call OI Ratio 0.34
  • Today's Open Interest 6,014
  • Open Int (30-Day) 7,121

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.26
  • Number of Estimates 3
  • High Estimate -0.24
  • Low Estimate -0.29
  • Prior Year -0.36
  • Growth Rate Est. (year over year) +27.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
26.30 +5.97%
on 07/19/21
35.37 -21.20%
on 07/15/21
-6.11 (-17.98%)
since 07/02/21
3-Month
20.80 +33.99%
on 05/11/21
35.37 -21.20%
on 07/15/21
-0.20 (-0.71%)
since 05/04/21
52-Week
11.51 +142.14%
on 10/30/20
49.50 -43.70%
on 03/22/21
+9.29 (+50.00%)
since 08/04/20

Most Recent Stories

More News
TransMedics Receives FDA Clearance of OCS Lung Solution for Cold Preservation of Lungs

/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, today...

TMDX : 27.87 (-0.18%)
TransMedics to Participate in the Canaccord Genuity 41st Annual Growth Conference

/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure,...

TMDX : 27.87 (-0.18%)
TransMedics to Report Second Quarter 2021 Financial Results on August 5, 2021

/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure,...

TMDX : 27.87 (-0.18%)
Should You Invest in the SPDR S&P Health Care Equipment ETF (XHE)?

Sector ETF report for XHE

XHE : 128.61 (-0.23%)
BLFS : 48.20 (-0.60%)
LNTH : 26.11 (-1.88%)
IHI : 63.46 (-0.56%)
TMDX : 27.87 (-0.18%)
MDEV : 26.85 (+0.05%)
TransMedics Announces Positive FDA Advisory Committee Vote for the OCS Liver System

/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure,...

TMDX : 27.87 (-0.18%)
TransMedics Stock Trading Halted Today; FDA Advisory Committee to Review Premarket Approval Application for the OCS Liver System

/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced...

TMDX : 27.87 (-0.18%)
TransMedics Announces Scheduling of OCS Liver FDA Advisory Committee Meeting

/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure,...

TMDX : 27.87 (-0.18%)
TransMedics Announces Presentation of OCS Liver PROTECT Trial Results and is Recognized as Winner of The People's Choice Award for Most Impactful Presentation at the American Transplant Congress (ATC 2021)

/PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart, and liver failure, announced...

TMDX : 27.87 (-0.18%)
Anavex Life Sciences Announces Appointment of Ms Jiong Ma, PhD to Board of Directors

Strengthening Board of Directors with Expertise in Innovative Product Launches

TMDX : 27.87 (-0.18%)
PRAH : 165.21 (-1.67%)
AVXL : 17.49 (-2.56%)
TransMedics (TMDX) Reports Q1 Loss, Tops Revenue Estimates

TransMedics (TMDX) delivered earnings and revenue surprises of -3.57% and 1.78%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

TMDX : 27.87 (-0.18%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

TransMedics Inc. is a commercial-stage medical technology company. It is engaged in transforming organ transplant therapy for end-stage organ failure patients. The company offers Organ Care System, an integrated, compact, portable preservation technology which addresses unmet need for organs for transplantation....

See More

Key Turning Points

3rd Resistance Point 30.75
2nd Resistance Point 30.03
1st Resistance Point 28.95
Last Price 27.87
1st Support Level 27.15
2nd Support Level 26.42
3rd Support Level 25.34

See More

52-Week High 49.50
Fibonacci 61.8% 34.99
Fibonacci 50% 30.51
Last Price 27.87
Fibonacci 38.2% 26.02
52-Week Low 11.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar